Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Issakov

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Oncogene|October 7, 2004
Prediction of high risk Ewing's sarcoma by gene expression profilingAnat Ohali, Smadar Avigad, Rina Zaizov, et al.
Gynecologic and Obstetric Investigation|September 20, 2007
The complexity of management of pregnancy-associated malignant soft tissue and bone tumorsRinat Bernstein Molho, Yehuda Kollender, Josephine Issakov, et al.
Cancer|February 26, 2004
The predictive potential of molecular detection in the nonmetastatic Ewing family of tumorsSmadar Avigad, Ian J Cohen, Julia Zilberstein, et al.
Journal of Pediatric Hematology/Oncology|December 21, 2018
Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94Shifra Ash, Isaac Yaniv, Helen Toledano, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2019
SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWSIan Joseph Cohen, Helen Toledano, Jerry Stein, et al.
Journal of Pediatric Surgery|February 18, 2017
Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literatureVered Shkalim Zemer, Helen Toledano, Liora Kornreich, et al.
Journal of Cellular and Molecular Medicine|October 30, 2010
Pre-clinical and clinical significance of heparanase in Ewing's sarcomaItay Shafat, Myriam Weyl Ben-Arush, Josephine Issakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Short telomeres: a novel potential predictor of relapse in Ewing sarcomaSmadar Avigad, Inna Naumov, Anat Ohali, et al.
Human Pathology|April 17, 2002
Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcomeGail Amir, Josephine Issakov, Isaac Meller, et al.
Oncotarget|September 23, 2015
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growthMichal Hameiri-Grossman, Adi Porat-Klein, Isaac Yaniv, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Oncogene|October 7, 2004
Prediction of high risk Ewing's sarcoma by gene expression profilingAnat Ohali, Smadar Avigad, Rina Zaizov, et al.
Gynecologic and Obstetric Investigation|September 20, 2007
The complexity of management of pregnancy-associated malignant soft tissue and bone tumorsRinat Bernstein Molho, Yehuda Kollender, Josephine Issakov, et al.
Cancer|February 26, 2004
The predictive potential of molecular detection in the nonmetastatic Ewing family of tumorsSmadar Avigad, Ian J Cohen, Julia Zilberstein, et al.
Journal of Pediatric Hematology/Oncology|December 21, 2018
Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94Shifra Ash, Isaac Yaniv, Helen Toledano, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2019
SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWSIan Joseph Cohen, Helen Toledano, Jerry Stein, et al.
Journal of Pediatric Surgery|February 18, 2017
Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literatureVered Shkalim Zemer, Helen Toledano, Liora Kornreich, et al.
Journal of Cellular and Molecular Medicine|October 30, 2010
Pre-clinical and clinical significance of heparanase in Ewing's sarcomaItay Shafat, Myriam Weyl Ben-Arush, Josephine Issakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Short telomeres: a novel potential predictor of relapse in Ewing sarcomaSmadar Avigad, Inna Naumov, Anat Ohali, et al.
Human Pathology|April 17, 2002
Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcomeGail Amir, Josephine Issakov, Isaac Meller, et al.
Oncotarget|September 23, 2015
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growthMichal Hameiri-Grossman, Adi Porat-Klein, Isaac Yaniv, et al.
Pageof 4